Auxier Asset Management Johnson & Johnson Transaction History

Auxier Asset Management

$672 Million
Q3 2024

A detailed history of Auxier Asset Management transactions in Johnson & Johnson stock. As of the latest transaction made, Auxier Asset Management holds 72,621 shares of JNJ stock, worth $10.5 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares

72,621

Previous 72,779 0.22%

Holding current value

$10.5 Million

Previous $10.6 Million 10.63%

% of portfolio

1.75%

Previous 1.69%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $22,985 - $26,446	-158 Reduced 0.22%	72,621 $11.8 Million
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $267,247 - $292,050	-1,851 Reduced 2.48%	72,779 $10.6 Million
Q1 2024 May 08, 2024	SELL	$155.22 - $162.74 $140,008 - $146,791	-902 Reduced 1.19%	74,630 $11.8 Million
Q4 2023 Feb 22, 2024	SELL	$145.6 - $158.88 $106,724 - $116,459	-733 Reduced 0.96%	75,532 $11.8 Million
Q3 2023 Nov 21, 2023	SELL	$155.75 - $174.48 $467,405 - $523,614	-3,001 Reduced 3.79%	76,265 $11.9 Million
Q2 2023 Aug 17, 2023	BUY	$154.35 - $166.11 $75,785 - $81,560	491 Added 0.62%	79,266 $13.1 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $299,834 - $357,816	1,985 Added 2.58%	78,775 $12.2 Million
Q4 2022 Feb 17, 2023	SELL	$160.2 - $179.79 $9,612 - $10,787	-60 Reduced 0.08%	76,790 $13.6 Million
Q3 2022 Nov 15, 2022	SELL	$161.33 - $179.52 $334,114 - $371,785	-2,071 Reduced 2.62%	76,850 $12.6 Million
Q2 2022 Aug 11, 2022	SELL	$168.19 - $186.01 $252,285 - $279,015	-1,500 Reduced 1.87%	78,921 $14 Million
Q1 2022 May 17, 2022	SELL	$158.14 - $179.59 $469,517 - $533,202	-2,969 Reduced 3.56%	80,421 $14.3 Million
Q4 2021 Mar 01, 2022	SELL	$155.93 - $173.01 $343,825 - $381,487	-2,205 Reduced 2.58%	83,390 $14.3 Million
Q3 2021 Nov 18, 2021	SELL	$161.5 - $179.47 $30,362 - $33,740	-188 Reduced 0.22%	85,595 $13.8 Million
Q2 2021 Aug 18, 2021	SELL	$159.48 - $171.07 $633,933 - $680,003	-3,975 Reduced 4.43%	85,783 $14.1 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $29,083 - $32,391	-190 Reduced 0.21%	89,758 $14.8 Million
Q4 2020 Mar 05, 2021	SELL	$137.11 - $157.38 $36,608 - $42,020	-267 Reduced 0.3%	89,948 $14.2 Million
Q3 2020 Mar 05, 2021	SELL	$140.38 - $153.83 $34,393 - $37,688	-245 Reduced 0.27%	90,215 $13.4 Million
Q2 2020 Aug 20, 2020	SELL	$128.81 - $155.51 $340,058 - $410,546	-2,640 Reduced 2.84%	90,460 $12.7 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $52,235 - $72,375	-470 Reduced 0.5%	93,100 $12.2 Million
Q4 2019 Feb 21, 2020	SELL	$127.5 - $146.44 $29,962 - $34,413	-235 Reduced 0.25%	93,570 $13.6 Million
Q3 2019 Nov 15, 2019	SELL	$126.95 - $142.14 $12,695 - $14,213	-100 Reduced 0.11%	93,805 $12.1 Million
Q2 2019 Aug 15, 2019	SELL	$131.15 - $144.24 $380,335 - $418,296	-2,900 Reduced 3.0%	93,905 $13.1 Million
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $9,429 - $10,484	-75 Reduced 0.08%	96,805 $13.5 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $267,791 - $322,291	-2,180 Reduced 2.2%	96,880 $12.5 Million
Q3 2018 Nov 19, 2018	SELL	$121.58 - $142.88 $36,474 - $42,864	-300 Reduced 0.3%	99,060 $13.7 Million
Q2 2018 Aug 15, 2018	SELL	$119.4 - $131.76 $79,998 - $88,279	-670 Reduced 0.67%	99,360 $12.1 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $53,167 - $62,959	-425 Reduced 0.42%	100,030 $12.8 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $314,403 - $344,113	-2,396 Reduced 2.33%	100,455 $14 Million
Q3 2017 Nov 09, 2017	SELL	$129.47 - $135.38 $71,208 - $74,459	-550 Reduced 0.53%	102,851 $13.4 Million
Q2 2017 Aug 16, 2017	BUY	N/A	103,401	103,401 $13.7 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxier Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Auxier Asset Management with notifications on news.

Account

Auxier Asset Management Johnson & Johnson Transaction History